Non Regulatory June 16, 2026 Vivesto reports positive results from i.v. Cantrixil PK/toxicology study
Regulatory April 1, 2026 The Board of Directors of Vivesto proposes a reverse share split and reduction of the share capital
Regulatory January 29, 2026 Vivesto carries out a directed share issue to guarantors in connection with the completed rights issue
